4598.T
Price:
$500
Market Cap:
$5.75B
Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 that is in phase III clinical trial in the United States and phase I trial in Japan for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323, which is in phase III clinical trial to treat lung cancer; DFP-17729 that is in phase I/II clinical trials for the treatment of solid cancer; DFP-11207, which has completed phase I clinical trial to treat pancreatic cancer; DFP-14927 that is in phase I for the treatment of hematologic cancer; and DFP-10825, which is in preclinical trial to treat gastric/ovarian cancer. Delta-Fly Pharma, Inc. was incorporated in 2010 and is headquartered in Tokushima, Japan.
Industry
Biotechnology
IPO Date
2018-10-12
Stock Exchange
JPX
Ticker
4598.T
According to Delta-Fly Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -332.90%. This represents a change of 237.07% compared to the average of -98.76% of the last 4 quarters.
The mean historical ROE of Delta-Fly Pharma, Inc. over the last ten years is -123.17%. The current -332.90% ROE has changed 170.28% with respect to the historical average. Over the past ten years (40 quarters), 4598.T's ROE was at its highest in in the March 2021 quarter at -4.30%. The ROE was at its lowest in in the March 2025 quarter at -148.81%.
Average
-123.17%
Median
-75.63%
Minimum
-619.58%
Maximum
39.69%
Discovering the peaks and valleys of Delta-Fly Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 434.30%
Maximum Annual ROE = 39.69%
Minimum Annual Increase = -175.44%
Minimum Annual ROE = -619.58%
| Year | ROE | Change |
|---|---|---|
| 2025 | -619.58% | 434.30% |
| 2024 | -115.96% | -30.95% |
| 2023 | -167.95% | 114.11% |
| 2022 | -78.44% | 89.03% |
| 2021 | -41.50% | -45.13% |
| 2020 | -75.63% | 293.79% |
| 2019 | -19.21% | -35.86% |
| 2018 | -29.94% | -175.44% |
The current ROE of Delta-Fly Pharma, Inc. (4598.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-301.16%
5-year avg
-204.68%
10-year avg
-123.17%
Delta-Fly Pharma, Inc.’s ROE is greater than D. Western Therapeutics Institute, Inc. (-103.32%), greater than Carna Biosciences, Inc. (-131.01%), greater than FunPep Company Limited (-66.75%), greater than Ribomic Inc. (-34.56%), greater than Soiken Holdings Inc. (-3.50%), greater than Kubota Pharmaceutical Holdings Co., Ltd. (-56.69%), less than Immuno-Biological Laboratories Co., Ltd. (17.76%), greater than PRISM BioLab Co.,LTD (-28.18%), greater than Trans Genic Inc. (-17.63%), greater than Kringle Pharma, Inc. (-59.06%),
| Company | ROE | Market cap |
|---|---|---|
| -103.32% | $4.29B | |
| -131.01% | $8.39B | |
| -66.75% | $3.08B | |
| -34.56% | $3.55B | |
| -3.50% | $6.07B | |
| -56.69% | $2.63B | |
| 17.76% | $13.21B | |
| -28.18% | $6.15B | |
| -17.63% | $4.25B | |
| -59.06% | $2.65B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Delta-Fly Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Delta-Fly Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Delta-Fly Pharma, Inc.'s ROE?
How is the ROE calculated for Delta-Fly Pharma, Inc. (4598.T)?
What is the highest ROE for Delta-Fly Pharma, Inc. (4598.T)?
What is the 3-year average ROE for Delta-Fly Pharma, Inc. (4598.T)?
What is the 5-year average ROE for Delta-Fly Pharma, Inc. (4598.T)?
How does the current ROE for Delta-Fly Pharma, Inc. (4598.T) compare to its historical average?